VOLUME 58   1997   NUMBER 5

BRAINSTORMS

183 Apoptosis: Neuronal Death by Design. Stephen M. Stahl
[PDF]

ORIGINAL ARTICLES

185 A Comparison of Nefazodone and Fluoxetine on Mood and on Objective, Subjective, and Clinician-Rated Measures of Sleep in Depressed Patients: A Double-Blind, 8-Week Clinical Trial. J. Christian Gillin, Mark Rapaport, Milton K. Erman, Andrew Winokur, and Bruce J. Albala
[Abstract] [PDF]

193 Chronic Neuroleptic Exposure in Bipolar Outpatients. Michael J. Sernyak, Linda S. Godleski, Ruth A. Griffin, Carolyn M. Mazure, and Scott W. Woods
[Abstract] [PDF]

196 The Role of the Alliance in the Pharmacologic Treatment of Depression. Margaret Weiss, Louise Gaston, Arthur Propst, Susan Wisebord, and Vivian Zicherman
[Abstract] [PDF]

205 Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia. .c.Pierre V. Tran, Mary Anne Dellva, Gary D. Tollefson, Charles M. Beasley, Jr., Janet H. Potvin, and Gerilyn M. Kiesler
[Abstract] [PDF]

212 Frontotemporal Dementia: Treatment Response to Serotonin Selective Reuptake Inhibitors. J. Randolph Swartz, Bruce L. Miller, Ira M. Lesser, and Amy L. Darby
[Abstract] [PDF]

LETTERS TO THE EDITOR

218 Reversible Dyskinesia During Bupropion Therapy. George Gardos
[PDF]

218 A Case of Seasonal Trichotillomania. Susana Feldman-Naim and Norman E. Rosenthal
[PDF]

219 Clozapine-Related Speech Disturbance. James L. Knoll IV
[PDF]

Reply by Michael Bauer and Friedel M. Reischies [PDF]

220 Paroxetine-Induced Anorexia in a Patient With Bulimia Nervosa. Kemal Sagduyu
[PDF]

Reply by Francisco J. Vaz [PDF]

BOOK REVIEW 222

CME Article

223 Novel Alternatives and Supplements to Lithium and Anticonvulsants for Bipolar Affective Disorder. Steven L. Dubovsky and Randall D. Buzan
[Abstract] [PDF]

Information for Authors

see January 1995, pages 3-4